Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This appears to be a combination of four different medications, each with distinct pharmacological properties and mechanisms of action. The combination includes: 1. Metoclopramide - an antiemetic and prokinetic agent 2. Codeine phosphate - an opioid analgesic 3. Ibuprofen - a non-steroidal anti-inflammatory drug (NSAID) 4. Paracetamol (acetaminophen) - a non-opioid analgesic ## Pharmacological Components **Metoclopramide** functions as an antiemetic by inhibiting dopamine D2 and serotonin 5-HT3 receptors in the chemoreceptor trigger zone (CTZ) of the brain[2]. It also has prokinetic effects through its actions on various receptors, enhancing gastric emptying and transit through the gut[2]. **Codeine phosphate** is an opioid analgesic that works by affecting pain receptors in the central nervous system and brain to block pain signals[4][6]. It's commonly used for mild to moderate pain relief and as a cough suppressant[6][7]. **Ibuprofen** is an NSAID that works by inhibiting prostaglandin synthesis, thereby reducing inflammation, pain, and fever[3][4]. **Paracetamol** (acetaminophen) is an analgesic and antipyretic, though its exact mechanism of action is not fully understood. It's believed to work centrally by inhibiting prostaglandin synthesis in the brain[5]. ## Potential Uses and Considerations While this specific four-drug combination is not mentioned as a standard formulation in the search results, similar combinations exist for specific conditions: - The combination of paracetamol and metoclopramide (Paramax) is used to treat migraine, addressing both the headache (paracetamol) and associated nausea/vomiting (metoclapramide)[5]. - Codeine is often combined with other analgesics like paracetamol or ibuprofen to enhance pain relief[3][5]. ## Safety Considerations Several important drug interactions and safety concerns should be noted: 1. Codeine should not be taken with other codeine-containing products or other opioids[1][4]. 2. Ibuprofen should not be combined with other NSAIDs, including aspirin, as this increases the risk of side effects like stomach bleeding[4]. 3. Metoclopramide can interact with various medications, including those for mental health conditions, high blood pressure, and infections[1][7]. 4. Prolonged use of codeine carries a risk of dependence and addiction[4][7]. This specific four-drug combination would need careful medical supervision due to the potential for multiple drug interactions and side effects from each component.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on metoclopramide + codeine phosphate + ibuprofen + paracetamol.